SK13097A3 - Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use - Google Patents
Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use Download PDFInfo
- Publication number
- SK13097A3 SK13097A3 SK130-97A SK13097A SK13097A3 SK 13097 A3 SK13097 A3 SK 13097A3 SK 13097 A SK13097 A SK 13097A SK 13097 A3 SK13097 A3 SK 13097A3
- Authority
- SK
- Slovakia
- Prior art keywords
- optically active
- ester
- pharmaceutically acceptable
- active compound
- amide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/457,538 US5652242A (en) | 1993-03-29 | 1995-06-01 | Heterocyclic derivatives |
GBGB9518188.9A GB9518188D0 (en) | 1995-09-07 | 1995-09-07 | Optically active derivative |
PCT/GB1996/001260 WO1996038416A1 (fr) | 1995-06-01 | 1996-05-28 | Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyrique inhibiteur d'adhesion cellulaire |
Publications (1)
Publication Number | Publication Date |
---|---|
SK13097A3 true SK13097A3 (en) | 1997-08-06 |
Family
ID=26307696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK130-97A SK13097A3 (en) | 1995-06-01 | 1996-05-28 | Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0796247A1 (fr) |
JP (1) | JP2885941B2 (fr) |
KR (1) | KR100245957B1 (fr) |
AT (1) | AT406675B (fr) |
AU (1) | AU710105B2 (fr) |
BE (1) | BE1009520A5 (fr) |
BR (1) | BR9606409A (fr) |
CA (1) | CA2194397A1 (fr) |
CH (1) | CH691808A5 (fr) |
CZ (1) | CZ26997A3 (fr) |
DE (1) | DE19680509T1 (fr) |
DK (1) | DK10697A (fr) |
ES (1) | ES2137886B1 (fr) |
FI (1) | FI970393A (fr) |
GB (1) | GB2304340B (fr) |
GR (1) | GR1002702B (fr) |
HU (1) | HUP9700274A3 (fr) |
IE (1) | IE960405A1 (fr) |
IL (1) | IL118477A0 (fr) |
IT (1) | IT1290839B1 (fr) |
LU (1) | LU90008B1 (fr) |
MC (1) | MC2418A1 (fr) |
MX (1) | MX9700379A (fr) |
NL (1) | NL1003243C2 (fr) |
NO (1) | NO307460B1 (fr) |
NZ (1) | NZ308597A (fr) |
PL (1) | PL318440A1 (fr) |
SE (1) | SE510812C2 (fr) |
SK (1) | SK13097A3 (fr) |
TR (1) | TR199700020T1 (fr) |
WO (1) | WO1996038416A1 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0100158A3 (fr) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | Hétéroalkysylalkanoles 3-pyridinyliques, leurs acides alkanoiques et leurs esters |
GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
ZW4194A1 (en) * | 1993-03-29 | 1994-12-21 | Zeneca Ltd | Heterocyclic compounds |
PT825184E (pt) * | 1993-03-29 | 2001-11-30 | Astrazeneca Ab | Derivados heterociclicos como inibidores de agregacao de plaquetas |
-
1996
- 1996-05-28 JP JP8536281A patent/JP2885941B2/ja not_active Expired - Fee Related
- 1996-05-28 ES ES009750006A patent/ES2137886B1/es not_active Expired - Fee Related
- 1996-05-28 NZ NZ308597A patent/NZ308597A/en unknown
- 1996-05-28 GB GB9627127A patent/GB2304340B/en not_active Expired - Fee Related
- 1996-05-28 AT AT0900596A patent/AT406675B/de active
- 1996-05-28 TR TR97/00020T patent/TR199700020T1/xx unknown
- 1996-05-28 SK SK130-97A patent/SK13097A3/sk unknown
- 1996-05-28 HU HU9700274A patent/HUP9700274A3/hu unknown
- 1996-05-28 GR GR960100176A patent/GR1002702B/el not_active IP Right Cessation
- 1996-05-28 DE DE19680509T patent/DE19680509T1/de not_active Withdrawn
- 1996-05-28 CZ CZ97269A patent/CZ26997A3/cs unknown
- 1996-05-28 MX MX9700379A patent/MX9700379A/es unknown
- 1996-05-28 WO PCT/GB1996/001260 patent/WO1996038416A1/fr not_active IP Right Cessation
- 1996-05-28 AU AU58272/96A patent/AU710105B2/en not_active Ceased
- 1996-05-28 BR BR9606409A patent/BR9606409A/pt not_active Application Discontinuation
- 1996-05-28 CH CH00224/97A patent/CH691808A5/de not_active IP Right Cessation
- 1996-05-28 PL PL96318440A patent/PL318440A1/xx unknown
- 1996-05-28 CA CA002194397A patent/CA2194397A1/fr not_active Abandoned
- 1996-05-28 EP EP96919906A patent/EP0796247A1/fr not_active Withdrawn
- 1996-05-28 KR KR1019970700532A patent/KR100245957B1/ko not_active IP Right Cessation
- 1996-05-29 MC MC2347A patent/MC2418A1/fr unknown
- 1996-05-30 IL IL11847796A patent/IL118477A0/xx unknown
- 1996-05-31 BE BE9600491A patent/BE1009520A5/fr not_active IP Right Cessation
- 1996-05-31 IE IE960405A patent/IE960405A1/en not_active IP Right Cessation
- 1996-05-31 NL NL1003243A patent/NL1003243C2/xx not_active IP Right Cessation
- 1996-05-31 IT IT96MI001113A patent/IT1290839B1/it active IP Right Grant
-
1997
- 1997-01-22 LU LU90008A patent/LU90008B1/fr active
- 1997-01-24 SE SE9700203A patent/SE510812C2/sv not_active IP Right Cessation
- 1997-01-30 FI FI970393A patent/FI970393A/fi unknown
- 1997-01-30 DK DK010697A patent/DK10697A/da not_active Application Discontinuation
- 1997-01-31 NO NO970437A patent/NO307460B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69912379T2 (de) | Antithrombosemittel | |
US6333337B1 (en) | Potassium channel inhibitors | |
SK120895A3 (en) | Pyridine derivatives, process for preparing the same and intermediate products in this process and pharmaceutical compositions containing them | |
JP2002528495A (ja) | ニトロソ化およびニトロシル化された非ステロイド抗炎症性化合物、組成物および使用方法 | |
KR101373911B1 (ko) | Bcl 단백질과 결합 파트너의 상호작용을 억제하기 위한화합물 및 방법 | |
US4873253A (en) | Phenylalanine derivative and proteinase inhibitor | |
CZ297544B6 (cs) | Substituované N-[(aminoiminomethyl)-fenyl]propylamidy nebo N-[(aminomethyl)fenyl]propylamidy | |
SK16512000A3 (sk) | Heterocyklické deriváty inhibujúce faktor xa, farmaceutická kompozícia s ich obsahom a ich použitie | |
SK6992000A3 (en) | Compounds useful as competitive inhibitors of trypsin-like serine proteases, method for the preparation thereof, pharmaceutical compositions containing same and their use | |
EP1124824B1 (fr) | Derives de chromenone et de chromanone utilises comme inhibiteurs d'integrine | |
AU2009248231A1 (en) | Novel N-(2-amino-phenyl)-acrylamides | |
JPH09502448A (ja) | 心臓血管系に活性な2−アミノ−1,2,3,4−テトラヒドロナフタレン誘導体 | |
FR2758329A1 (fr) | Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique | |
AU2004276128A1 (en) | Amide-type carboxamide derivatives | |
US4963587A (en) | Glycine derivative and pharmaceutical preparation thereof | |
SK13097A3 (en) | Optically active (-)-(3r)-3-methyl-4-{4-£4-(4-pyridyl)piperazin- -1-yl|phenoxy} butyric acid and its derivatives, preparation method thereof and their use | |
JPH0717942A (ja) | 化合物 | |
EP0718307A2 (fr) | Dérivés de 1-oxo-2-(phénylsulfonyl-amino)pentylpipéridine, leur préparation et leur application en thérapeutique | |
CN102924567B (zh) | 一类肽化合物、其制备方法及用途 | |
US5672712A (en) | Thiazoline derivatives | |
NZ336003A (en) | Use of compositions containing diarylalkane derivatives for treating or preventing pancreatitis | |
MXPA05006032A (es) | Derivado cristalino de 2-(5 -clorotien -2-il) -n -{(3s) -1-[(1s) -1-metil -2-morfolin -4-il -2- oxoetil] -2- oxopirrolidin- 3-il} etenosulfonamida. | |
JPH02311479A (ja) | キノリン誘導体 | |
FR2734818A1 (fr) | Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant |